These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21883908)

  • 1. Impact of MELD-based allocation on end-stage renal disease after liver transplantation.
    Sharma P; Schaubel DE; Guidinger MK; Goodrich NP; Ojo AO; Merion RM
    Am J Transplant; 2011 Nov; 11(11):2372-8. PubMed ID: 21883908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-specific prediction of ESRD after liver transplantation.
    Sharma P; Goodrich NP; Schaubel DE; Guidinger MK; Merion RM
    J Am Soc Nephrol; 2013 Dec; 24(12):2045-52. PubMed ID: 24029423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.
    Goldberg DS; Ruebner RL; Abt PL
    Am J Transplant; 2015 Oct; 15(10):2732-8. PubMed ID: 25969133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal outcomes after liver transplantation in the model for end-stage liver disease era.
    Sharma P; Welch K; Eikstadt R; Marrero JA; Fontana RJ; Lok AS
    Liver Transpl; 2009 Sep; 15(9):1142-8. PubMed ID: 19718633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sodium and survival benefit of liver transplantation.
    Sharma P; Schaubel DE; Goodrich NP; Merion RM
    Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (MELD) era.
    Malinis MF; Chen S; Allore HG; Quagliarello VJ
    Ann Transplant; 2014 Sep; 19():478-87. PubMed ID: 25256592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation.
    Cholankeril G; Li AA; Dennis BB; Gadiparthi C; Kim D; Toll AE; Maliakkal BJ; Satapathy SK; Nair S; Ahmed A
    Sci Rep; 2019 Jun; 9(1):8312. PubMed ID: 31165776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P
    J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Assessment of Hospitalization Rates for Incident End-Stage Renal Disease After Liver Transplantation.
    Goodrich NP; Schaubel DE; Smith AR; Merion RM; Sharma P
    Transplantation; 2016 Oct; 100(10):2115-21. PubMed ID: 27467539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation.
    Raza MH; Kwon Y; Kobierski P; Misra AC; Lim A; Goldbeck C; Etesami K; Kohli R; Emamaullee J
    Liver Transpl; 2023 Feb; 29(2):134-144. PubMed ID: 35876731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pretransplant serum creatinine on the survival benefit of liver transplantation.
    Sharma P; Schaubel DE; Guidinger MK; Merion RM
    Liver Transpl; 2009 Dec; 15(12):1808-13. PubMed ID: 19938142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-liver transplant renal dysfunction and association with post-transplant end-stage renal disease: A single-center examination of updated UNOS recommendations.
    Chauhan K; Azzi Y; Faddoul G; Liriano-Ward L; Chang P; Nadkarni G; Delaney V; Ames S; Debnath N; Singh N; Sehgal V; Di Boccardo G; Garzon F; Nair V; Kent R; Lerner S; Coca S; Shapiro R; Florman S; Schiano T; Menon MC
    Clin Transplant; 2018 Dec; 32(12):e13428. PubMed ID: 30338873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National assessment of early hospitalization after liver transplantation: Risk factors and association with patient survival.
    Sharma P; Goodrich NP; Schaubel DE; Smith AR; Merion RM
    Liver Transpl; 2017 Sep; 23(9):1143-1152. PubMed ID: 28688150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
    Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.
    Bambha KM; Dodge JL; Gralla J; Sprague D; Biggins SW
    Liver Transpl; 2015 Oct; 21(10):1286-94. PubMed ID: 26097202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone.
    Sharma P; Goodrich NP; Zhang M; Guidinger MK; Schaubel DE; Merion RM
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1135-42. PubMed ID: 23449770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
    Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
    Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
    Sharma P; Schaubel DE; Messersmith EE; Guidinger MK; Merion RM
    Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.